<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date15177140.9 (espacenet)  (Federated)  (European Patent Register), 20030320
Patent/reg. no. and dateDK/EP 2962690, 20190116
Publication date20160106
Priority no. and dateUS 366515 P, 20020320, US 438450 P, 20030107
EP pub. no. and date EP 2962690 20160106
Effective date
Applicant/ownerAmgen (Europe) GmbH, Floor 6-8
Suurstoffi 22
Risch-Rotkreuz 6343, CH
Applicant ref. no.P67782DK01
InventorMan, Hon-wah, 27 Grant Way
Princeton, NJ 08540, US,
GE, Chuansheng, 9 Breckenridge Court
Belle Mead, NJ 08502, US,
Muller, George W., P.O. Box 3688
Rancho Santa Fe, CA 92067, US,
SCHAFER, Peter H., 237 Monroe Avenue
Belle Mead, NJ 08502, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/4035 (2006.01) , A61P 35/00 (2006.01) , C07C 317/28 (2006.01) , C07D 209/48 (2006.01) 
Title(+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION: FREMGANGSMÅDER TIL ANVENDELSE OG SAMMENSÆTNINGER DERAF
Int. application no.
Int. publication no.
Related patent (certificate)CA 2019 00033
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact